Are Superficial Parasternal Intercostal Plane (SPIP) Blocks With Bupivacaine and With or Without Adjuvants Helpful for Post-operative Pain After Coronary Artery Bypass Grafting?
Status unconfirmed · Not applicable
Conditions studied: Post-operative Pain Management
In brief
The purpose of this study is to determine whether the addition of the superficial parasternal intercostal plane (SPIP) block alone (30cc of 0.25% bupivacaine) or plus Magnesium (200mg of magnesium sulfate) or plus Magnesium + Buprenorphine (300mcg) as adjuvants can improve post-operative pain in patients undergoing cardiothoracic surgery, specifically, coronary artery bypass grafting (CABG)
Key facts
- Study ID
- NCT05003765
- Run by
- Wayne State University
- People needed
- 200
- Starts
- 2020-08-06
- Expected to finish
- 2022-05-01
- Last updated by the study team
- 2021-08-12
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients undergoing primary coronary artery bypass grafting
You may not qualify if…
- Patients with significant genetic or acquired clotting/bleeding disorders (hemophilia, DIC, etc.)
- Patients with significant platelet dysfunction
- Infection at site for regional anesthesia
- Allergy to local anesthetics
- Severe aortic stenosis
- Severe mitral stenosis
- Sepsis
Where it is running
- St. Joseph Mercy Oakland Hospital — Pontiac, Michigan, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.